LeoBen Research (LBR) develops brain health assessment digital technologies for a global healthcare market. LBR addresses the unmet healthcare need of superior cost-efficiencies and cost-effectiveness in the clinical management of brain disease conditions. LBR product development pipeline stems from an original proprietary highly-scalable platform technology; it includes clinical tools for use in early diagnosis, disease progression evaluation, for therapeutic or rehabilitative intervention monitoring in healthcare and clinical research settings. LBR executes product development from design to regulatory marketing authorization approval LBR pursues a commercial strategy based on maximizing the value of the intellectual property (IP) we generate (i.e., patent rights, know-how, clinical trial data package, etc.). LBR sells to worldwide healthcare providers and bio-pharmaceutical companies. Passionate in what we do, open and transparent in what we say, for us patients always come first. We think globally and enjoy being part of the worldwide, vibrant, scientific community.